Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/08/21 → 31/12/23 |
Keywords
- Hereditary angioedema
- Clinical trial
Clinical Trial Phase
- Phase III (a & b)
An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema
- Zubrinich, Celia (Primary Chief Investigator (PCI))
Project: Research